Skytte A‐B, Gerdes A‐M, Andersen MK, Sunde L, Brøndum‐Nielsen K, Waldstrøm M,
Kølvraa S, Crüger D. Risk‐reducing mastectomy and salpingo‐oophorectomy in unaffected …

OBJECTIVE: Despite substantial survival benefits of risk-reducing mastectomy (RRM) and
risk-reducing bilateral salpingo-oophorectomy (RRBSO) among BRCA mutation carriers …

Women with germline BRCA1 mutation have a significant risk of breast and/or ovarian
cancer. Prophylactic bilateral mastectomy (PBM) and prophylactic bilateral salpingo …

Inherited mutations in BRCA1 or BRCA2 (BRCA1/2) confer very high risk of breast and
ovarian cancers. Genetic testing and counseling can reduce risk and death from these …

Introduction and Aims: For women who carry BRCA mutations, risk-reducing surgeries are
an option to decrease breast and ovarian cancer risk. This study aims to determine the …

Purpose To evaluate prophylactic salpingo-oophorectomy uptake and timing among
BRCA1/2 mutation carriers in a cancer risk assessment program. Methods Clinical records …

Context Mastectomy and salpingo-oophorectomy are widely used by carriers of BRCA1 or
BRCA2 mutations to reduce their risks of breast and ovarian cancer. Objective To estimate …

The aim of this study was to evaluate the outcome of risk-reducing mastectomy in BRCA1/2
mutation carriers with and without breast cancer. Uptake, methods of operation and …

Skytte A‐B, Crüger D, Gerster M, Lænkholm A‐V, Lang C, Brøndum‐Nielsen K, Andersen
MK, Sunde L, Kølvraa S, Gerdes A‐M. Breast cancer after bilateral risk‐reducing …

Purpose: The uptake of risk-reducing surgery in women at increased risk of breast and
ovarian cancer is highly variable between countries and centers within countries. We have …